Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety study of udenafil hydrochloride tablets in patients with erectile dysfunction
CTR20240170Phase 3Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of udenafil in erectile dysfunction (ED), sponsored by Yangtze River Pharmaceutical Group. Started Jan 2024; status: completed.
02
Drugs
udenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on CTR20240170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240170.